KCNN2 and melanoma: Further, miconazole targets the KCNN2 gene; this gene appears to be the best candidate among the five identified in Table 3, being the only one with AUC > 0.90 in both screening phase and first validation phase, and with very high melanoma vs. ctrl expression ratios (see Table 3).